Davidson Kempner Capital Management »

Viridian Therapeutics shares owned by Davidson Kempner Capital Management

Quarter-by-quarter ownership of Viridian Therapeutics shares owned by Davidson Kempner Capital Management from 13F filings

Historical chart of Davidson Kempner Capital Management investment in Viridian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viridian Therapeutics held by Davidson Kempner Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viridian Therapeutics by Davidson Kempner Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.1M 1.0M 1.07

More positions owned by Davidson Kempner Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Electronic Arts (EA)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Space Exploration Techn Corp Class A Com Stk Put Option (SPCX)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Echostar Corp Cl A
Arko Corp (ARKO)
Cerebras Systems Com Cl A (CBRS)
MKS Note 1.250% 6/0 (Principal)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Uber Technologies Note 0.875%12/0 (Principal)
Rivian Automotive Note 4.625% 3/1 (Principal)
Li Auto Note 0.250% 5/0 (Principal)
Redfin Corp Note 0.500% 4/0 (Principal)

View all positions for Davidson Kempner Capital Management

Top funds holding Viridian Therapeutics

Context Capital Management
Citadel Advisors
Polar Securities
Ubs Global Asset Management Americas
D. E. Shaw & Co
Linden Advisors
DeepCurrents Investment Group
Nuveen
Jane Street
Tenor Capital Management
Silverback Asset Management
BlackRock
Nicholas Investments Partners
Capstone Investment Advisors
CSS

View all funds holding Viridian Therapeutics